These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2249187)

  • 1. Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
    Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
    Cancer; 1990 Dec; 66(12):2470-5. PubMed ID: 2249187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
    Kemeny N; Younes A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):171-5. PubMed ID: 1557642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
    John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
    Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
    Greco FA; Figlin R; York M; Einhorn L; Schilsky R; Marshall EM; Buys SS; Froimtchuk MJ; Schuller J; Schuchter L; Buyse M; Ritter L; Man A; Yap AK
    J Clin Oncol; 1996 Oct; 14(10):2674-81. PubMed ID: 8874326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
    Ragnhammar P; Blomgren H; Edler D; Lundell G; Magnusson I; Sonnenfeld T
    Eur J Cancer; 1995; 31A(3):315-20. PubMed ID: 7786594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
    Piga A; Cascinu S; Latini L; Marcellini M; Bavosi M; Acito L; Bascioni R; Giustini L; Francini G; Pancotti A; Rossi G; Del Papa M; Carle F; Cellerino R
    Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
    Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
    Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ; Manola J; Valone FH; Ryan LM; Hines JD; Wadler S; Haller DG; Arbuck SG; Weiner LM; Mayer RJ; Benson AB
    J Clin Oncol; 2001 May; 19(9):2413-21. PubMed ID: 11331320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study.
    Dufour P; Husseini F; Dreyfus B; Cure H; Martin C; Prevost G; Olivier JP; Dumas F; Duclos B; Olivares R; Leszler A; Bergerat JP; Audhuy B; Thill L; Oberling F
    Ann Oncol; 1996 Aug; 7(6):575-9. PubMed ID: 8879370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma.
    Wadler S; Wiernik PH
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):16-21; discussion 38-41. PubMed ID: 2405491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Knauf WU; Boese-Landgraf J; Schalhorn A; Zeitz M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A report of infusional 5-fluorouracil and subcutaneous alpha-2A-interferon in the treatment of advanced colorectal carcinoma.
    Koo WH; Ang PT
    Ann Acad Med Singap; 1996 Mar; 25(2):210-4. PubMed ID: 8799007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME; McGarry W; Bready B; Dakhil SR; Belt RJ; Goodwin JW; Gray R; Hoff PM; Winn R; Pazdur R
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.
    Steger GG; Mader RM; Djavanmard MP; Gnant MF; Locker G; Marosi C; Rainer H; Jakesz R
    J Cancer Res Clin Oncol; 1994; 120(5):314-8. PubMed ID: 8126062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
    Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
    Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
    Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
    Köhne CH; Schöffski P; Wilke H; Käufer C; Andreesen R; Ohl U; Klaasen U; Westerhausen M; Hiddemann W; Schott G; Harstick A; Bade J; Horster A; Schubert U; Hecker H; Dörken B; Schmoll HJ
    J Clin Oncol; 1998 Feb; 16(2):418-26. PubMed ID: 9469324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.